WHO Approves Chinese COVID Vaccine for Emergency Use Worldwide
Vaccine was developed by Chinese drugmaker SinopharmActualités similaires
Articles similaires à WHO Approves Chinese COVID Vaccine for Emergency Use Worldwide
Ireland awaits another Covid-19 vaccine after EMA approves Novavax
Ireland is ready to get another Covid-19 vaccine after the European Medicines Agency gave the...Chinese Scientists Developing Inhalable COVID Vaccine
China has approved a vaccine for people between the ages of 3 and 17WHO Secures $2.4 Billion for Global COVID-19 Vaccine Sharing
Japan's $800 million pledge is largest made to COVAX initiativeActualités similaires
WHO Approves Chinese-Made COVID Vaccine for Emergency Use
Vaccine developed by Sinovac is effective in over half of those who were vaccinatedWHO Calls for 20 Million Vaccine Doses for Africa
Agency cites 17% jump in infectionsActualités similaires
EU Authorizes Pfizer-BioNTech COVID-19 Vaccine for Young Adolescents
Britain approves Johnson & Johnson's vaccine, its fourth vaccine approvalMacron in South Africa for Talks on COVID Vaccine
Presidents Emmanuel Macron and Cyril Ramaphosa will launch a program at the University of Pretoria to support African vaccine productionActualités similaires
Moderna Says COVID-19 Vaccine Safe and Effective for 12 - 17 Year Olds
Tests conducted on 3,700 adolescents produced same results as adultsUS Approves Pfizer COVID-19 Vaccine for Children as Young as 12
WHO: Variant circulating in India is of 'global' concernWHO Approves Chinese COVID Vaccine for Emergency Use Worldwide
Vaccine was developed by Chinese drugmaker SinopharmActualités similaires
WHO Approves China COVID Vaccine for Emergency Use
Sinopharm first non-Western vaccine approved by WHOActualités similaires
WHO Concerned About Spike in Global COVID Cases for 9th Straight Week
More COVID cases in past two weeks than in pandemic's first six monthsActualités similaires
WHO: COVID Cases Increase for Ninth Week
More COVID cases in past two weeks than in pandemic's first six monthsActualités similaires
WHO: India, Brazil Account for Half of New Global COVID-19 Cases
Director-general says many other countries face fragile situationsNew York State to Resume Use of Johnson & Johnson COVID Vaccine
New York Governor Cuomo announces move despite evidence that the vaccine has been found to be linked to rare cases of blood clotsActualités similaires
Malawi Rejects WHO Call to Use Expired COVID Vaccine
The WHO and Africa CDC this week urged African countries not to destroy COVID-19 vaccines that may have passed their expiration date, saying they are still safe ...Actualités similaires
US Agencies OK Resumption of J&J COVID Vaccine Use Despite Clot Risk
Government found 15 vaccine recipients who had developed rare blood clots, out of nearly 8 million people given the J&J shot; FDA, CDC decide J&J vaccine use is ...Actualités similaires
Beijing Pushing for Vaccine Passport for Those Inoculated with Chinese Vaccines
Worry over lower efficacy of China's vaccines could be offset by the lure of easier travel/Actualités similaires
India Approves Russian Vaccine While Battling Devastating COVID Surge
Move will give country access to third vaccine at a time when race to ramp up immunization drive is being hampered by shortagesActualités similaires
US Urges Pause in Use of Johnson & Johnson Single-Shot COVID-19 Vaccine
Centers for Disease Control and Prevention and Food and Drug Administration cite reports of blood clots among six women after receiving doseActualités similaires
WHO Reports COVID-19 Cases Rose Globally for 7th Straight Week
Cases surge despite 780 million vaccine doses delivered; Tedros blames 'confusion, complacency and inconsistency in public health measures'WHO Warns of Rising COVID Cases, Cites Vaccine Complacency
The latest report by the UN agency confirms more than 133.5 million infections, including nearly 3 million global deathsPfizer, BioNTech Seek US Emergency OK for COVID-19 Vaccine in Adolescents
The vaccine is currently authorized for emergency use in the United States for people age 16 and olderActualités similaires
Malawi Expands Eligibility for COVID Vaccine as Doses Near Expiration
Critics question why Malawi accepted doses with short shelf lifeActualités similaires
WHO: Africa Left Behind in Race for COVID-19 Vaccine
World Health Organization says Africa's rollout of COVID-19 vaccine is being hampered by supply shortages and delays in planned deliveries• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
